Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel network

Arnett D.K. Blumenthal R.S. Albert M.A. Buroker A.B. Goldberger Z.D. Hahn E.J. et al.

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Circulation. 2019; 140: e596-e646

Polypharmacy as a risk factor in the treatment of type 2 diabetes.

Diabetes Spectr. 2006; 19: 13-16Cosentino F. Grant P.J. Aboyans V. Bailey C.J. Ceriello A. Delgado V. et al.

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.

Eur. Heart J. 2020; 41: 255-323Calderón-Larrañaga A. Poblador-Plou B. González-Rubio F. Gimeno-Feliu L.A. Abad-Díez J.M. Prados-Torres A.

Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?.

Br. J. Gen. Pract. 2012; 62: e821-6

Protecting Resources, Promoting Value: a Doctor’s Guide to Cutting Waste in Clinical Care.

Academy of Medical Royal Colleges, Centre for Sustainable Healthcare, 2014

Disinvestment: the UK experience.

15th Annual European Congress. 2012; Bryant E. Claire K. Needham R.

Reducing Inappropriate Polypharmacy in Primary Care Through Pharmacy-led Interventions.

([cited 2020 5th January]. Available from:)2019

An educational intervention, involving feedback of routinely collected computer data, to improve cardiovascular disease management in UK primary care.

Methods Inf. Med. 2007; 46: 57-62Tuti T. Nzinga J. Njoroge M. Brown B. Peek N. English M. et al.

A systematic review of electronic audit and feedback: intervention effectiveness and use of behaviour change theory.

Implement. Sci. 2017; 12: 61Burningham Z. Jackson G.L. Kelleher J. Stevens M. Morris I. Cohen J. et al.

The enhancing quality of prescribing practices for older veterans discharged from the emergency department (EQUIPPED) potentially inappropriate medication dashboard: a suitable alternative to the in-person academic detailing and standardized feedback reports of traditional EQUIPPED?.

Clin. Ther. 2020; 42: 573-582Dixon B.E. Jabour A.M. Phillips E.O. Marrero D.G.

Improving medication adherence for chronic disease using integrated e-technologies.

Stud. Health Technol. Inform. 2013; 192: 929National Institute for Health and Care Excellence

Type 2 Diabetes in Adults: Management (NICE Guideline 28).

2015 ([cited 2021 6th January]. Available from: https://www.nice.org.uk/guidance/ng28/resources/type-2-diabetes-in-adults-management-pdf-1837338615493)Correa A. Hinton W. McGovern A. van Vlymen J. Yonova I. Jones S. et al.

Royal College of general practitioners research and surveillance centre (RCGP RSC) sentinel network: a cohort profile.

BMJ Open. 2016; 6e011092de Lusignan S. Correa A. Smith G.E. Yonova I. Pebody R. Ferreira F. et al.

RCGP research and surveillance centre: 50 years’ surveillance of influenza, infections, and respiratory conditions.

Br. J. Gen. Pract. 2017; 67: 440-441

The use of financial incentives to help improve health outcomes: is the quality and outcomes framework fit for purpose? A systematic review.

J. Public Health Oxf. (Oxf.). 2014; 36: 251-258McGovern A. Hinton W. Correa A. Munro N. Whyte M. de Lusignan S.

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.

BMJ Open. 2016; 6e012801National Institute for Health and Care Excellence

Do Not Do Recommendation.

([cited 2021 22nd January]. Available from:)2016National Institute for Health and Care Excellence

Do Not Do Recommendation.

([cited 2021 22nd January]. Available from:)2015Li L. Geraghty O.C. Mehta Z. Rothwell P.M.

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study.

Lancet. 2017; 390: 490-499McNeil J.J. Wolfe R. Woods R.L. Tonkin A.M. Donnan G.A. Nelson M.R. et al.

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly.

N. Engl. J. Med. 2018; 379: 1509-1518American Diabetes Association

Aspirin therapy in diabetes.

Diabetes Care. 2004; 27: s72-s73

Clinical dashboards: impact on workflow, care quality, and patient safety.

Crit. Care Nurs. Q. 2006; 29: 354-361Koopman R.J. Kochendorfer K.M. Moore J.L. Mehr D.R. Wakefield D.S. Yadamsuren B. et al.

A diabetes dashboard and physician efficiency and accuracy in accessing data needed for high-quality diabetes care.

Ann. Fam. Med. 2011; 9: 398-405Lusignan S. Gallagher H. Jones S. Chan T. van Vlymen J. Tahir A. et al.

Audit-based education lowers systolic blood pressure in chronic kidney disease: the quality improvement in CKD (QICKD) trial results.

Kidney Int. 2013; 84: 609-620Anderson D. Zlateva I. Khatri K. Ciaburri N.

Using health information technology to improve adherence to opioid prescribing guidelines in primary care.

Clin. J. Pain. 2015; 31: 573-579Peek N. Gude W.T. Keers R.N. Williams R. Kontopantelis E. Jeffries M. et al.

Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in UK primary care: an interrupted time series analysis.

PLoS Med. 2020; 17e1003286Bowman L. Mafham M. Wallendszus K. Stevens W. Buck G. Barton J. et al.

Effects of aspirin for primary prevention in persons with diabetes mellitus.

N. Engl. J. Med. 2018; 379: 1529-1539Campbell H.E. Stokes E.A. Bargo D. Logan R.F. Mora A. Hodge R. et al.

Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial.

BMJ Open. 2015; 5e007230Huang E.S. Strate L.L. Ho W.W. Lee S.S. Chan A.T.

Long-term use of aspirin and the risk of gastrointestinal bleeding.

Am. J. Med. 2011; 124: 426-433Flory J.H. Hennessy S. Bailey C.J. Inzucchi S.E.

Reports of lactic acidosis attributed to metformin, 2015-2018.

Diabetes Care. 2020; 43: 244-246Giaccari A. Solini A. Frontoni S. Del Prato S.

Metformin benefits: another example for alternative energy substrate mechanism?.

Diabetes Care. 2021; 44: 647-654Lazarus B. Wu A. Shin J.I. Sang Y. Alexander G.C. Secora A. et al.

Association of metformin use with risk of lactic acidosis across the range of kidney function: a community-based cohort study.

JAMA Intern. Med. 2018; 178: 903-910

留言 (0)

沒有登入
gif